The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000527.5(LDLR):c.710G>A (p.Arg237His)

CA044568

375798 (ClinVar)

Gene: LDLR
Condition: hypercholesterolemia, familial
Inheritance Mode: Semidominant inheritance
UUID: 16a530f6-e753-42cb-8dbc-19a74a20358d
Approved on: 2022-04-29
Published on: 2025-02-13

HGVS expressions

NM_000527.5:c.710G>A
NM_000527.5(LDLR):c.710G>A (p.Arg237His)
NC_000019.10:g.11106580G>A
CM000681.2:g.11106580G>A
NC_000019.9:g.11217256G>A
CM000681.1:g.11217256G>A
NC_000019.8:g.11078256G>A
NG_009060.1:g.22200G>A
ENST00000252444.10:c.968G>A
ENST00000559340.2:c.710G>A
ENST00000560467.2:c.710G>A
ENST00000558518.6:c.710G>A
ENST00000252444.9:c.964G>A
ENST00000455727.6:c.314-812G>A
ENST00000535915.5:c.587G>A
ENST00000545707.5:c.329G>A
ENST00000557933.5:c.710G>A
ENST00000558013.5:c.710G>A
ENST00000558518.5:c.710G>A
ENST00000558528.1:n.225G>A
ENST00000560467.1:c.310G>A
NM_000527.4:c.710G>A
NM_001195798.1:c.710G>A
NM_001195799.1:c.587G>A
NM_001195800.1:c.314-812G>A
NM_001195803.1:c.329G>A
NM_001195798.2:c.710G>A
NM_001195799.2:c.587G>A
NM_001195800.2:c.314-812G>A
NM_001195803.2:c.329G>A
More

Uncertain Significance

Met criteria codes 2
PP3 PM2
Not Met criteria codes 6
BS3 PS3 PS4 PS1 PP4 PM5

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Familial Hypercholesterolemia VCEP
NM_000527.5(LDLR):c.710G>A (p.Arg237His) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2 and PP3 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 29 April 2022. The supporting evidence is as follows: PM2: PopMax MAF = 0.00008673 (0.009%) in Latino/Admixed American exomes (gnomAD v2.1.1). PP3: REVEL = 0.751. It is above 0.75.
Met criteria codes
PP3
REVEL = 0.751. It is above 0.75.
PM2
PopMax MAF = 0.00008673 (0,009%) in atino/Admixed American exomes (gnomAD v2.1.1).
Not Met criteria codes
BS3
This variant shown to have benign impact in Thormaehlen study (PMID 25647241), but whole cycle is not studied, so not met
PS3
This variant shown to have benign impact in Thormaehlen study (PMID 25647241)
PS4
No index case that fulfil FH criteria is reported. So neither PS4 nor PP4 is met.
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP4
No index case that fulfil FH criteria is reported. So neither PS4 nor PP4 is met.
PM5
There is one other missense variant in the same codon NM_000527.5(LDLR):c.709C>T (p.Arg237Cys). It is considered as Uncertain significance - insufficient evidence by this guidelines. PM5 is not met.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.